The “Artificial Intelligence and Cancers” (AICP) Association was born of a ground-breaking public-private partnership: in order to make France a landmark ecosystem, attractive at the global level, it is our conviction that public and private expertise are needed in combination.
Our ambition can be summed up in a single sentence: to address, drawing upon all the data available in France, questions that bring value to patients and can give rise to tangible innovations.
Accompanying this ambition are other objectives: speeding up projects and access to data; and working to ensure the admissibility of projects to the regulatory authorities.
Towards this end, the entire project sector has mobilised: health data are both the fruit and the raw material for innovation.
We are ready to provide support to those wishing to submit a project proposal.
These projects address such issues as healthcare pathways, personalised medicine and research on new biomarkers. They are selected by our Board of Directors on the basis of three broad families of criteria: the importance of the therapeutic advances targeted; the potential for the national ecosystem; and the contribution to the Project’s profile.